Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Evotec WD in Hamburg is seeking a biology-focused professional to develop and implement cellular assays for target validation, including primary cells, cell lines, and transfection workflows. The role emphasizes establishing robust plate- and image-based readouts within a multidisciplinary team.
You will apply genome editing tools such as CRISPR/Cas9, plan and perform experiments, analyze DNA, RNA and protein data, and document results in the electronic lab notebook to meet project timelines.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
EN: In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
IT: In compliance with fundamental ethical and professional principles and with Legislative Decree 198/2006, Evotec is an Equal Opportunity Employer committed to fostering a safe, diverse, and inclusive workplace built on mutual respect.
We provide equal employment opportunities to all qualified candidates and employees based on their skills, experience, and professional qualifications.
In line with our ethical and professional principles, all employment-related decisions, including recruitment and selection processes, are made fairly and without any form of discrimination.
All qualified candidates will be considered for employment regardless of race, color, sex, age, disability, genetic information, gender expression, gender identity, nationality, religion, sexual orientation, or any other characteristic protected under applicable law.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients.
The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products.
Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders.
Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.
Evotec operates globally with more than 5,000 highly qualified people.
The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.